$CRTD
Creatd, Inc. Stock $crtd

$crtd Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023066977 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	$437.9K	$699.4K	$800.0K
YoY Change	-57.19%	-56.99%	-43.07%
Cost Of Revenue	$359.7K	$437.6K	$1.340M
YoY Change	-74.39%	-75.61%	17.62%
Gross Profit	$78.16K	$261.8K	-$540.0K
YoY Change	-120.47%	-255.34%	-302.98%
Gross Profit Margin	17.85%	37.43%	-67.5%
Selling, General & Admin	$719.0K	$1.649M	$4.030M
YoY Change	-83.97%	-69.79%	-63.65%
% of Gross Profit	919.91%	630.06%
Research & Development	$543.2K	$46.30K	$270.0K
YoY Change	131.17%	-79.38%	-1.86%
% of Gross Profit	694.98%	17.69%
Depreciation & Amortization	$50.00K	$60.00K	$150.0K
YoY Change	14.82%	-57.76%	-25.93%
% of Gross Profit	63.98%	22.92%
Operating Expenses	$2.001M	$2.974M	$4.290M
YoY Change	-64.24%	-61.99%	-62.24%
Operating Profit	-$1.923M	-$2.713M	-$4.830M
YoY Change	-67.83%	-66.06%	-56.47%
Interest Expense	$473.5K	$93.98K	-$110.0K
YoY Change	-29.72%	361.6%	108.25%
% of Operating Profit
Other Income/Expense, Net	-$480.0K	-$1.710M	-$2.400M
YoY Change	-74.53%	166.8%	595.13%
Pretax Income	-$2.919M	-$4.466M	-$10.56M
YoY Change	-69.36%	-48.7%	-15.2%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.919M	-$4.450M	-$12.38M
YoY Change	-68.37%	-46.62%	0.73%
Net Earnings / Revenue	-666.6%	-636.35%	-1547.5%
Basic Earnings Per Share	-$0.09	-$0.12
Diluted Earnings Per Share	-$0.09	-$0.12	-$0.42
COMMON SHARES
Basic Shares Outstanding	117.5M shares	86.47M shares	29.07M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.00K	$100.0K	$710.0K
YoY Change	-97.73%	-93.77%	-81.29%
Cash & Equivalents	$6.759K	$104.2K	$706.2K
Short-Term Investments
Other Short-Term Assets	$2.007M	$2.210M	$2.973M
YoY Change	-28.63%	-45.47%	-25.04%
Inventory	$112.4K	$170.4K	$405.0K
Prepaid Expenses
Receivables	$35.10K	$67.57K	$239.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$363.7K	$710.4K	$1.479M
YoY Change	-78.36%	-72.69%	-66.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$140.8K	$179.3K	$212.5K
YoY Change	-43.44%	-28.56%	106.48%
Goodwill	$46.46K	$46.46K	$46.46K
YoY Change	-96.6%	-96.64%	-96.62%
Intangibles		$191.3K	$230.1K
YoY Change		-92.43%	-90.54%
Long-Term Investments	$300.0K	$870.0K	$800.0K
YoY Change	-61.0%	-25.6%	4.04%
Other Assets
YoY Change
Total Long-Term Assets	$2.528M	$3.218M	$3.341M
YoY Change	-64.1%	-57.25%	-28.89%
TOTAL ASSETS
Total Short-Term Assets	$363.7K	$710.4K	$1.479M
Total Long-Term Assets	$2.528M	$3.218M	$3.341M
Total Assets	$2.892M	$3.929M	$4.820M
YoY Change	-66.85%	-61.21%	-47.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.44M	$12.60M	$7.570M
YoY Change	100.16%	157.19%	102.92%
Accrued Expenses	$250.0K	$0.00	$330.0K
YoY Change	-10.58%	-100.0%	1688.62%
Deferred Revenue
YoY Change
Short-Term Debt	$1.588M	$1.474M	$1.684M
YoY Change	-11.14%	-22.22%	25.4%
Long-Term Debt Due	$1.588M	$1.474M	$1.646M
YoY Change	-79.7%	-64.52%	14.45%
Total Short-Term Liabilities	$21.69M	$20.73M	$15.21M
YoY Change	42.98%	118.31%	180.53%
LONG-TERM LIABILITIES
Long-Term Debt	$10.00K	$0.00	$40.00K
YoY Change	-65.42%	-100.0%	-37.49%
Other Long-Term Liabilities	$1.910M	$2.240M	$2.080M
YoY Change	-10.55%	6.63%
Total Long-Term Liabilities	$1.919M	$2.241M	$2.116M
YoY Change	-11.33%	5.08%	3206.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.69M	$20.73M	$15.21M
Total Long-Term Liabilities	$1.919M	$2.241M	$2.116M
Total Liabilities	$23.61M	$22.97M	$17.32M
YoY Change	36.2%	97.55%	215.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$190.5M	-$179.0M	-$146.1M
YoY Change	42.42%	43.99%	33.3%
Common Stock	$137.6K	$103.0K	$39.06K
YoY Change	462.32%	408.66%	134.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$78.46K		$78.46K
YoY Change	3.09%		25.72%
Treasury Stock Shares			93.37K shares
Shareholders Equity	-$21.61M	-$19.92M	-$11.75M
YoY Change
Total Liabilities & Shareholders Equity	$2.892M	$3.929M	$4.820M
YoY Change	-66.85%	-61.21%	-47.46%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$2.919M	-$4.450M	-$12.38M
YoY Change	-68.37%	-46.62%	0.73%
Depreciation, Depletion And Amortization	$50.00K	$60.00K	$150.0K
YoY Change	14.82%	-57.76%	-25.93%
Cash From Operating Activities	-$190.0K	-$330.0K	-$2.950M
YoY Change	-94.13%	-94.09%	-39.82%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$210.0K
YoY Change	-100.0%	-100.0%	-800.7%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$1.090M
YoY Change	-100.0%	-100.0%	482.92%
Cash From Investing Activities	$0.00	$0.00	$860.0K
YoY Change	-100.0%	-100.0%	447.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	90.00K	270.0K	2.350M
YoY Change	-96.06%	-93.65%	-66.69%
NET CHANGE
Cash From Operating Activities	-190.0K	-330.0K	-2.950M
Cash From Investing Activities	0.000	0.000	860.0K
Cash From Financing Activities	90.00K	270.0K	2.350M
Net Change In Cash	-100.0K	-60.00K	260.0K
YoY Change	-90.75%	-96.36%	-88.75%
FREE CASH FLOW
Cash From Operating Activities	-$190.0K	-$330.0K	-$2.950M
Capital Expenditures	$0.00	$0.00	$210.0K
Free Cash Flow	-$190.0K	-$330.0K	-$3.160M
YoY Change	-94.05%	-93.79%	-35.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	crtd	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
	crtd	Weighted Average Remaining Contractual Lifein Years Forfeited Cancelled WeightedAverageRemainingContractualLifeinYearsForfeitedCancelled
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39500
	dei	Entity Registrant Name EntityRegistrantName	Creatd, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0645394
	dei	Entity Address Address Line1 EntityAddressAddressLine1	419 Lafayette Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	6th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10003
	dei	City Area Code CityAreaCode	(201)
	dei	Local Phone Number LocalPhoneNumber	258-3770
	dei	Security12b Title Security12bTitle	N/A
	dei	Trading Symbol TradingSymbol	N/A
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	117519724	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104201	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	706224	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	67573	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	239423	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	170385	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	404970	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	368231	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	128547	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	710390	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1479164	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	179254	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	212545	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	191253	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	230084	usd
CY2023Q2	us-gaap	Goodwill Goodwill	46460	usd
CY2022Q4	us-gaap	Goodwill Goodwill	46460	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	874517	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	797231	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1926963	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2054265	usd
CY2023Q2	us-gaap	Assets Assets	3928837	usd
CY2022Q4	us-gaap	Assets Assets	4819749	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12598276	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7565720	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	6326916	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	5369599	usd
CY2022Q4	crtd	Operating Lease Payable Long Term OperatingLeasePayableLongTerm	326908	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1474130	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1645680	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	321763	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	299409	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13144	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20734229	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15207316	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	38014	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2240650	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2077618	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2240650	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2115632	usd
CY2023Q2	us-gaap	Liabilities Liabilities	22974879	usd
CY2022Q4	us-gaap	Liabilities Liabilities	17322948	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	450	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	450	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	450	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	450	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	103029348	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102935974	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39062386	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38969013	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	103029	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	39062	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	159042399	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	134570600	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	93373	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	93373	shares
CY2023Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	78456	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	78456	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-179064680	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-146142373	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	80335	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-140183	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19917373	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11751350	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	871331	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-751849	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-19046042	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12503199	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3928837	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4819749	usd
CY2023Q2	us-gaap	Revenues Revenues	699364	usd
CY2022Q2	us-gaap	Revenues Revenues	1625901	usd
	us-gaap	Revenues Revenues	1685509	usd
	us-gaap	Revenues Revenues	2974639	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	437586	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1794419	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1450274	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3366589	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	261778	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-168518	usd
	us-gaap	Gross Profit GrossProfit	235235	usd
	us-gaap	Gross Profit GrossProfit	-391950	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	721059	usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	901480	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4835582	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1774992	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46301	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	224512	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	177927	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	451166	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	371809	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1277510	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	907330	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3369531	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	557707	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2141218	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7885751	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3222010	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1277538	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3280186	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2852897	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5793359	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2974414	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	7824906	usd
	us-gaap	Operating Expenses OperatingExpenses	16659487	usd
	us-gaap	Operating Expenses OperatingExpenses	14611058	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2712636	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7993424	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16424252	usd
CY2023Q2	us-gaap	Dividends Dividends		usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15003008	usd
	us-gaap	Interest Income Other InterestIncomeOther	12000	usd
	us-gaap	Interest Income Other InterestIncomeOther	99	usd
CY2022Q2	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities	-17392	usd
	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities	23589	usd
	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities	-2867	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	93981	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	20360	usd
	us-gaap	Interest Expense InterestExpense	159351	usd
	us-gaap	Interest Expense InterestExpense	34256	usd
CY2023Q2	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	1705067	usd
CY2022Q2	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	623531	usd
	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	3860225	usd
	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	647008	usd
CY2023Q2	crtd	Derivative Expense DerivativeExpense	-45826	usd
	crtd	Derivative Expense DerivativeExpense	13144	usd
	crtd	Change In Derivative Liability ChangeInDerivativeLiability	3729	usd
CY2022Q2	crtd	Impairment Of Investment ImpairmentOfInvestment	-50000	usd
	crtd	Impairment Of Investment ImpairmentOfInvestment	-50000	usd
CY2022Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-231	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-231	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	147256	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1753222	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-711514	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-3997131	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-583278	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4465858	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8704938	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20421383	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15586286	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-4465858	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-8704938	usd
	us-gaap	Profit Loss ProfitLoss	-20421383	usd
	us-gaap	Profit Loss ProfitLoss	-15586286	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-15450	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-367872	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-64640	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-985758	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4450408	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-8337066	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20356743	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14600528	usd
CY2023Q2	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	6228318	usd
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	12565564	usd
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	81728	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10678726	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8337066	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-32922307	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14682256	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-4465858	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-8704938	usd
	us-gaap	Profit Loss ProfitLoss	-20421383	usd
	us-gaap	Profit Loss ProfitLoss	-15586286	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	90547	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-24659	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	220518	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-29609	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4375311	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8729597	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20200865	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15615895	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91212856	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20233585	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77428872	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18977745	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12503199	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7291231	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	213750	usd
CY2023Q1	crtd	Bcf Issued With Note Payable BCFIssuedWithNotePayable	2000000	usd
CY2023Q1	crtd	Exercise Of Warrants To Stock ExerciseOfWarrantsToStock	753693	usd
CY2023Q1	crtd	Cash Received For Common Stock And Warrants CashReceivedForCommonStockAndWarrants	1050000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1417782	usd
CY2023Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	129971	usd
CY2023Q1	crtd	Sale Of Minority Interest In Og Collection Inc SaleOfMinorityInterestInOGCollectionINC	250000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-15955525	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15352297	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	452020	usd
CY2023Q2	crtd	Cash Received For Common Stock And Warrants CashReceivedForCommonStockAndWarrants	169138	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	26250	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	34158	usd
CY2023Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	90547	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-4465858	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-19046042	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3688252	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1067609	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	69000	usd
CY2022Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	115000	usd
CY2022Q1	crtd	Cash Received For Common Stock And Warrants CashReceivedForCommonStockAndWarrants	4997300	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	173456	usd
CY2022Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-4950	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-6881348	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3109319	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2187155	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37200	usd
CY2022Q2	crtd	Stock Warrants Issued With Note Payable StockWarrantsIssuedWithNotePayable	1895390	usd
CY2022Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-24659	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-8704938	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1500533	usd
	us-gaap	Profit Loss ProfitLoss	-20421383	usd
	us-gaap	Profit Loss ProfitLoss	-15586286	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72122	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	283947	usd
	crtd	Impairment Of Investment ImpairmentOfInvestment	-50000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7531	usd
	crtd	Accretion Of Debt Discount And Issuance Costs AccretionOfDebtDiscountAndIssuanceCosts	3860225	usd
	crtd	Accretion Of Debt Discount And Issuance Costs AccretionOfDebtDiscountAndIssuanceCosts	647007	usd
	crtd	Sharebased In Compensation SharebasedInCompensation	7885751	usd
	crtd	Sharebased In Compensation SharebasedInCompensation	3349362	usd
	crtd	Derivative Expense DerivativeExpense	13144	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-220518	usd
	crtd	Bad Debt Expense BadDebtExpense	75874	usd
	crtd	Bad Debt Expense BadDebtExpense	53166	usd
	crtd	Gain Losses On Extinguishment Of Debt GainLossesOnExtinguishmentOfDebt	147256	usd
	crtd	Vendor Debt VendorDebt	23589	usd
	crtd	Vendor Debt VendorDebt	-2867	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3729	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-231	usd
	us-gaap	Noncash Contribution Expense NoncashContributionExpense	71705	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-95976	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	86286	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-234585	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	128986	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	168434	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-66090	usd
	crtd	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-29107	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	77286	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	450378	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5056145	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1240586	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	22354	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	28424	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-65681	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-18451	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3190572	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10620456	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	170544	usd
	crtd	Cash Received From The Sale Of Minority Interest In Og Collection Inc CashReceivedFromTheSaleOfMinorityInterestInOGCollectionInc	-250000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	48878	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	44977	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	192795	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	250000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-367240	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	753693	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	570560	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1277614	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	991664	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1258442	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2626600	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3874736	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1839778	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	112275	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1219138	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4997301	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2338549	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8778934	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-29609	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-602023	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2238071	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	706224	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3794734	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	104201	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1556663	usd
	crtd	Shares Issued Convertible Notes Payable SharesIssuedConvertibleNotesPayable	1451940	usd
	crtd	Feature Issued With Convertible Note FeatureIssuedWithConvertibleNote	2000000	usd
	crtd	Shares Issued With Notes Payable SharesIssuedWithNotesPayable	26250	usd
	crtd	Shares Issued For Prepaid Services SharesIssuedForPrepaidServices	213750	usd
	crtd	Shares Issued For Prepaid Services SharesIssuedForPrepaidServices	106200	usd
	us-gaap	Stock Issued1 StockIssued1	1439837	usd
	crtd	Deemed Dividend DeemedDividend	12562834	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1 – Organization and Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Creatd, Inc., formerly Jerrick Media Holdings, Inc. (“we,” “us,” the “Company,” or “Creatd”), is a technology company focused on providing economic opportunities for creators, which it accomplishes through its four main business pillars: Creatd Labs, Creatd Partners, Creatd Ventures, and Creatd Studios. Creatd’s flagship product, Vocal, delivers a robust long-form, digital publishing platform organized into highly engaged niche-communities capable of hosting all forms of rich media content. Through Creatd’s proprietary algorithm dynamics, Vocal enhances the visibility of content and maximizes viewership, providing advertisers access to target markets that most closely match their interests. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was originally incorporated under the laws of the State of Nevada on December 30, 1999, under the name LILM, Inc. The Company changed its name on December 3, 2013, to Great Plains Holdings, Inc. as part of its plan to diversify its business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 5, 2016 (the “Closing Date”), GTPH, GPH Merger Sub, Inc., a Nevada corporation and wholly-owned subsidiary of GTPH (“Merger Sub”), and Jerrick Ventures, Inc., a privately-held Nevada corporation headquartered in New Jersey (“Jerrick”), entered into an Agreement and Plan of Merger (the “Merger”) pursuant to which the Merger Sub was merged with and into Jerrick, with Jerrick surviving as a wholly-owned subsidiary of GTPH (the “Merger”). GTPH acquired, pursuant to the Merger, all of the outstanding capital stock of Jerrick in exchange for issuing Jerrick’s shareholders (the “Jerrick Shareholders”), pro-rata, a total of 475,000 shares of GTPH’s common stock. In connection therewith, GTPH acquired 33,415 shares of Jerrick’s Series A Convertible Preferred Stock (the “Jerrick Series A Preferred”) and 8,064 shares of Series B Convertible Preferred Stock (the “Jerrick Series B Preferred”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Merger, on the Closing Date, GTPH and Kent Campbell entered into a Spin-Off Agreement (the “Spin-Off Agreement”), pursuant to which Mr. Campbell purchased from GTPH (i) all of GTPH’s interest in Ashland Holdings, LLC, a Florida limited liability company, and (ii) all of GTPH’s interest in Lil Marc, Inc., a Utah corporation, in exchange for the cancellation of 39,091 shares of GTPH’s Common Stock held by Mr. Campbell. In addition, Mr. Campbell assumed all debts, obligations and liabilities of GTPH, including any existing prior to the Merger, pursuant to the terms and conditions of the Spin-Off Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon closing of the Merger on February 5, 2016, the Company changed its business plan to that of Jerrick.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective February 28, 2016, GTPH entered into an Agreement and Plan of Merger (the “Statutory Merger Agreement”) with Jerrick, pursuant to which GTPH became the parent company of Jerrick Ventures, LLC, a wholly-owned operating subsidiary of Jerrick (the “Statutory Merger”) and GTPH changed its name to Jerrick Media Holdings, Inc. to better reflect its new business strategy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 11, 2019, the Company acquired 100% of the membership interests of Seller’s Choice, LLC, a New Jersey limited liability company (“Seller’s Choice”), a digital e-commerce agency.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 9, 2020, the Company filed a certificate of amendment with the Secretary of State of the State of Nevada to change our name to “Creatd, Inc.”, which became effective on September 10, 2020. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 4, 2021, the Company acquired 89% of the membership interests of Plant Camp, LLC, a Delaware limited liability company (“Plant Camp”), which the Company subsequently rebranded as Camp. Camp is a direct-to-consumer (DTC) food brand which creates healthy upgrades to classic comfort food favorites. The results of Plant Camp’s operations have been included since the date of acquisition in the Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 20, 2021, the Company acquired 44% of the membership interests of WHE Agency, Inc. WHE Agency, Inc, is a talent management and public relations agency based in New York (“WHE”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 9, 2023, the Company acquired an additional 51% of the equity interest in WHE Agency, Inc. bringing our total ownership to 95%. WHE has been consolidated due to the Company’s ownership of 55% voting control, and the results of operations have been included since the date of acquisition in the Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Between October 21, 2020, and August 16, 2021, the Company acquired 21% of the membership interests of Dune, Inc. Dune, Inc. is a direct-to-consumer brand focused on promoting wellness through its range of health-oriented beverages.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 3, 2021, the Company acquired an additional 29% of the membership interests of Dune, Inc., bringing our total membership interests to 50%. Dune, Inc., has been consolidated due to the Company’s ownership of 50% voting control, and the results of operations have been included since the date of acquisition in the Statements of Operations. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 25, 2023, the Company acquired an additional 23% equity interest in Dune, Inc. bringing our total ownership to 85%. Dune, Inc., has been consolidated due to the Company’s ownership of 50% voting control, and the results of operations have been included since the date of acquisition in the Statements of Operations. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 7, 2022, the Company acquired 100% of the membership interests of Denver Bodega, LLC, d/b/a Basis, a Colorado limited liability company (“Basis”). Basis is a direct-to-consumer functional beverage brand that makes high-electrolyte mixes meant to aid hydration. Denver Bodega, LLC has been consolidated due to the Company’s ownership of 100% voting control, and the results of operations have been included since the date of acquisition in the Statement of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2022, the Company acquired 51% of the membership interests of Orbit Media LLC, a New York limited liability company. Orbit is an app-based stock trading platform designed to empower a new generation of investors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 3, 2023, the Company acquired an additional 5% of the membership interests of Orbit Media, LLC., bringing our total membership interests to 56%. Orbit has been consolidated due to the Company’s ownership of 51% voting control, and the results of operations have been included since the date of acquisition in the Statement of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 13, 2022, the Company acquired 100% of the membership interests of Brave Foods, LLC, a Maine limited liability company. Brave is a plant-based food company that provides convenient and healthy breakfast food products. Brave Foods, LLC has been consolidated due to the Company’s ownership of 100% voting control, and the results of operations have been included since the date of acquisition in the Statement of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 13, 2022, an investor entered into a Subscription Agreement whereby it purchased from OG Collection, Inc., a subsidiary of the Company (“OG”), 150,000 shares of common stock of OG for a purchase price of $750,000, and, in connection therewith OG, the Company, and the Investor entered into a Shareholder Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">February 1, 2023, an investor entered into a Subscription Agreement whereby it purchased from OG Collection, Inc., a subsidiary of the Company (“OG”), 50,000 shares of common stock of OG for a purchase price of $250,000, and, in connection therewith OG, the Company, and the Investor entered into a Shareholder Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 30, 2023, the Company acquired an additional 15% equity interest in Dune, Inc. bringing our total ownership to 100%. Dune, Inc., has been consolidated due to the Company’s ownership of 50% voting control, and the results of operations have been included since the date of acquisition on October 3, 2021, in the Statements of Operations. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2023, the Company acquired an additional 10% of the membership interests of Plant Camp, LLC, bringing our total ownership to 100%. Plant Camp, LLC has been consolidated due to the Company’s ownership of 50% voting control, and the results of operations have been included since the date of acquisition on June 4, 2021, in the Statements of Operations. </p>
CY2023Q1	crtd	Membership Interest Percentage MembershipInterestPercentage	0.56	pure
CY2022Q4	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	150000	shares
CY2022Q4	crtd	Purchase Price PurchasePrice	750000	usd
CY2023Q1	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	50000	shares
CY2023Q1	crtd	Purchase Price PurchasePrice	250000	usd
CY2023Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2022Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	6810992	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Use of Estimates and Critical Accounting Estimates and Assumptions</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. The Company uses estimates in accounting for, among other items, revenue recognition, allowance for doubtful accounts, stock-based compensation, income tax provisions, excess and obsolete inventory reserve, and impairment of intellectual property.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Actual results could differ from those estimates.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Concentration of Credit Risk and Other Risks and Uncertainties</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides credit in the normal course of business. The Company maintains allowances for credit losses on factors surrounding the credit risk of specific customers, historical trends, and other information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates in Australia and holds total assets of $980,404. It is reasonably possible that operations located outside an entity’s home country will be disrupted in the near term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	980404	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P8Y6M3D
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	32097	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	32097	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	23176	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	20961	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	20961	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	61961	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	191253	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	191253	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	38831	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	147711	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	173680	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1426728	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1433815	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	46460	usd
CY2023Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	46460	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1645680	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	38014	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	699364	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1625901	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1685509	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2974639	usd
CY2023Q2	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	50227	usd
CY2022Q2	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	988283	usd
	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	1077779	usd
	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	2079657	usd
CY2023Q2	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	196837	usd
CY2022Q2	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	637618	usd
	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	636599	usd
	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	894982	usd
CY2023Q2	crtd	Revenue Recognition RevenueRecognition	699364	usd
CY2022Q2	crtd	Revenue Recognition RevenueRecognition	1625901	usd
	crtd	Revenue Recognition RevenueRecognition	1685509	usd
	crtd	Revenue Recognition RevenueRecognition	2974639	usd
	crtd	Management Fee Percentage ManagementFeePercentage	0.20	pure
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.80	pure
	crtd	Contract Occur Percentage ContractOccurPercentage	1	pure
	crtd	Promotional Discounts Amount PromotionalDiscountsAmount	9.99	usd
	crtd	Free Trials Amount FreeTrialsAmount	99	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	321763	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.06
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	300000	usd
CY2023Q2	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	15063	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	130000	usd
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.18	pure
	crtd	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	2803	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	264977	usd
	crtd	Common Stock Equivalents CommonStockEquivalents	216672306	shares
	crtd	Common Stock Equivalents CommonStockEquivalents	13723287	shares
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	51239	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	500	usd
CY2023Q2	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	6506073	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-179000000	usd
	us-gaap	Profit Loss ProfitLoss	-20400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3200000	usd
CY2022Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	34632	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	170385	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	370335	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	170385	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	404970	usd
CY2023Q2	crtd	Outstanding Principal Total OutstandingPrincipalTotal	1523364	usd
CY2022Q4	crtd	Outstanding Principal Total OutstandingPrincipalTotal	1997803	usd
	crtd	Debt Instrument Discount DebtInstrumentDiscount	49234	usd
	crtd	Debt Instrument Discount DebtInstrumentDiscount	314108	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1474130	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1683694	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1474130	usd
CY2023Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5477	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	14665	usd
CY2023Q2	crtd	Convertible Note Payable ConvertibleNotePayable	6326916	usd
CY2022Q4	crtd	Convertible Note Payable ConvertibleNotePayable	5369599	usd
	crtd	Repaid Amount RepaidAmount	188571	usd
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	562500	shares
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1387500	usd
	crtd	Beneficial Conversion Feature BeneficialConversionFeature	1250000	usd
CY2023Q2	crtd	Common Stock And Warrants Issued Upon Conversion Of Notes Payable CommonStockAndWarrantsIssuedUponConversionOfNotesPayable	2200000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	375000	shares
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.075
	us-gaap	Costs And Expenses CostsAndExpenses	96550	usd
	us-gaap	Costs And Expenses CostsAndExpenses	48655	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2
	crtd	Expected Dividend Yield Percentage ExpectedDividendYieldPercentage	0	pure
CY2023Q2	crtd	Shares Of Capital Stock SharesOfCapitalStock	1520000000	shares
CY2023Q2	crtd	Designated Of Common Stock Shares DesignatedOfCommonStockShares	-1500000000	shares
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2023Q2	crtd	Designated Of Preferred Stock DesignatedOfPreferredStock	-20000000	shares
CY2023Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.001
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1382744	shares
CY2023Q2	crtd	Gross Proceeds GrossProceeds	69137	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4408267	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.01
	crtd	Weighted Average Remaining Contractual Lifein Years Beginning Balance WeightedAverageRemainingContractualLifeinYearsBeginningBalance	P3Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	16667	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	14.1
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4391600	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.01
	crtd	Weighted Average Remaining Contractual Lifein Years Outstanding Ending Balance WeightedAverageRemainingContractualLifeinYearsOutstandingEndingBalance	P3Y9M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3756600	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M10D
	crtd	Option Outstanding Exercise Price OptionOutstandingExercisePrice	4.01
	crtd	Option Outstanding Number Outstanding OptionOutstandingNumberOutstanding	4391600	shares
	crtd	Option Outstanding Weighted Average Remaining Contractual Lifein Years OptionOutstandingWeightedAverageRemainingContractualLifeinYears	P3Y9M18D
	crtd	Option Outstanding Weighted Average Exercise Price OptionOutstandingWeightedAverageExercisePrice	4.42
	crtd	Option Exercisable Number Exercisable OptionExercisableNumberExercisable	3756600	shares
	crtd	Option Exercisable Weighted Average Remaining Contractual Lifein Years OptionExercisableWeightedAverageRemainingContractualLifeinYears	P3Y9M10D
CY2023Q2	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	7868533	usd
CY2023Q2	crtd	Unrecognized Compensation Expense UnrecognizedCompensationExpense	0	usd
CY2023Q1	crtd	Shares Issued1 SharesIssued1	3767925	shares
CY2023Q1	crtd	Warrant Holder Shares WarrantHolderShares	3767925	shares
CY2023Q1	crtd	Proceed From Warrant Exercises ProceedFromWarrantExercises	753693	usd
CY2023Q1	crtd	Warrants Exercisable Number Exercisable WarrantsExercisableNumberExercisable	3767925	shares
CY2023Q1	us-gaap	Dividends Cash DividendsCash	1625044	usd
CY2023Q1	crtd	Additional Warrant AdditionalWarrant	18837979	shares
CY2023Q1	crtd	Deemed Dividend DeemedDividend	3661981	usd
CY2023Q2	crtd	Warrant Share Issued Convertible Notes Payable WarrantShareIssuedConvertibleNotesPayable	2936100	shares
CY2023Q2	crtd	Stock Issued Period For Service StockIssuedPeriodForService	190935	usd
CY2023Q2	crtd	Additional Warrant Issued AdditionalWarrantIssued	88318466	usd
CY2022Q4	crtd	Seeking Damages SeekingDamages	161000	usd
CY2022Q4	crtd	Punitive Damages PunitiveDamages	500000	usd
CY2022Q2	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	920000	usd
CY2022Q3	us-gaap	Other Postretirement Benefits Payments OtherPostretirementBenefitsPayments	415000	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	5000	usd
CY2022Q3	us-gaap	Regulatory Liabilities RegulatoryLiabilities	420000	usd
CY2023Q2	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	415000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.15	pure
	crtd	Excise Tax On Net Repurchases Percentage ExciseTaxOnNetRepurchasesPercentage	0.01	pure
	crtd	Long Term Purchases Commitment Minimum Length Required LongTermPurchasesCommitmentMinimumLengthRequired	8000	sqm
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P7Y
	us-gaap	Lease Income LeaseIncome	3100693	usd
CY2022Q2	crtd	Lease Agreements Description LeaseAgreementsDescription	On April 19, 2022, the Company signed a 2-year lease for approximately 2,252 square feet of office space at 1 Westmount Square, Westmount, Qc H3Z2P9
CY2022Q2	us-gaap	Lease Income LeaseIncome	72064	usd
CY2022Q3	crtd	Lease Agreements Description LeaseAgreementsDescription	On July 28, 2022, the Company signed a 3-year lease for approximately 1,364 square feet of office space at 1674 Meridian Ave.
CY2022Q3	us-gaap	Lease Income LeaseIncome	181299	usd
CY2021Q3	crtd	Lease Agreements Description LeaseAgreementsDescription	On September 9, 2021, the Company signed a 1-year lease for approximately 3,200 square feet at 648 Broadway, Suite 200, New York, NY 10012. Monthly rent under the lease was $12,955 for the leasing period.
CY2022Q3	crtd	Stockholders Equity Requirement StockholdersEquityRequirement	On September 2, 2022, the Company received a letter from the staff of The Nasdaq Capital Market notifying the Company that the Nasdaq Hearings Panel has determined to delist the Company’s common stock from the Exchange, based on the Company’s failure to comply with the listing requirements of Nasdaq Rule 5550(b)(1) as a result of the Company’s shareholder equity deficit for the period ended June 30, 2022, as demonstrated in Company’s Quarterly Report on Form 10-Q filed on August 15, 2022, following the Company having not complied with the market value of listed securities requirement in Nasdaq Rule 5550(b)(2) on March 1, 2022, while the Company was under a Panel Monitor, as had been previously disclosed.
CY2023Q2	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	475000	usd
CY2022Q1	crtd	Purchase Price Per Share PurchasePricePerShare	1
	crtd	Schedule Of Excess Purchase Price Amounts ScheduleOfExcessPurchasePriceAmounts	The following table provides a summary of the preliminary allocation of the excess purchase price.<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">12,691</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names & Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,970</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,633</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,693</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">178,987</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">46,460</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names & Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,705</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,704</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Website</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,704</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,023</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">106,596</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	67573	usd
CY2023Q2	crtd	Prepaid Expense And Other Current Assets PrepaidExpenseAndOtherCurrentAssets	368231	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	874517	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	191253	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	46460	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	170385	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2210418	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	3928837	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	12598276	usd
CY2023Q2	crtd	Notes Payable And Convertible Notes Net Of Debt Discount And Issuance Costs NotesPayableAndConvertibleNotesNetOfDebtDiscountAndIssuanceCosts	7801046	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	321763	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2253794	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	22974879	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	239423	usd
CY2022Q4	crtd	Prepaid Expense And Other Current Assets PrepaidExpenseAndOtherCurrentAssets	128547	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	797231	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	230084	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	76585	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	374845	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2973034	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	4819749	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	7565720	usd
CY2022Q4	crtd	Notes Payable And Convertible Notes Net Of Debt Discount And Issuance Costs NotesPayableAndConvertibleNotesNetOfDebtDiscountAndIssuanceCosts	1683694	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	299409	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7774125	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	17322948	usd
CY2023Q2	crtd	Net Revenue NetRevenue	699364	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	437586	usd
CY2023Q2	crtd	Gross Margin GrossMargin	261778	usd
CY2023Q2	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	721059	usd
CY2023Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	46301	usd
CY2023Q2	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	371809	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	557707	usd
CY2023Q2	crtd	General And Administrative GeneralAndAdministrative	1214707	usd
CY2023Q2	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	62831	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2974414	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	93981	usd
CY2023Q2	crtd	All Other Expense AllOtherExpense	1659241	usd
CY2023Q2	crtd	Other Expenses Net OtherExpensesNet	-1753222	usd
CY2023Q2	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-4465858	usd
CY2022Q2	crtd	Net Revenue NetRevenue	1625901	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1794419	usd
CY2022Q2	crtd	Gross Margin GrossMargin	-168518	usd
CY2022Q2	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	901480	usd
CY2022Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	224512	usd
CY2022Q2	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1277510	usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	2141218	usd
CY2022Q2	crtd	General And Administrative GeneralAndAdministrative	4181666	usd
CY2022Q2	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	142055	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8868441	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	20360	usd
CY2022Q2	crtd	All Other Expense AllOtherExpense	691154	usd
CY2022Q2	crtd	Other Expenses Net OtherExpensesNet	-711514	usd
CY2022Q2	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-9748473	usd
	crtd	Net Revenue NetRevenue	1685509	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1450274	usd
	crtd	Gross Margin GrossMargin	235235	usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	4835582	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	177927	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	907330	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	7885751	usd
	crtd	General And Administrative GeneralAndAdministrative	2780775	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	72122	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	16659487	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	159351	usd
	crtd	All Other Expense AllOtherExpense	3837780	usd
	crtd	Other Expenses Net OtherExpensesNet	-3997131	usd
	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-20421383	usd
	crtd	Net Revenue NetRevenue	2974639	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3366589	usd
	crtd	Gross Margin GrossMargin	-391950	usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1774692	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	451166	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	3369531	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	3222010	usd
	crtd	General And Administrative GeneralAndAdministrative	5509712	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	283947	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14611058	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	34256	usd
	crtd	All Other Expense AllOtherExpense	549022	usd
	crtd	Other Expenses Net OtherExpensesNet	-583278	usd
	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-15586286	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	13000	usd
CY2023Q2	us-gaap	Common Stock Discount On Shares CommonStockDiscountOnShares	500	usd
	us-gaap	Subsequent Event Description SubsequentEventDescription	the Company entered into a loan agreement with a lender whereby the lender issued the Company a promissory note of $300,000. The note bears interest at a rate of 10% per annum and the Company is required to make monthly payments of $47,143 beginning in December of 2023. Upon an event of default, the note is convertible into the Company’s common stock at a price equal to 90% of the lowest per-share VWAP during the twenty-day trading period before the conversion. As additional consideration for entering into the note, the Company issued the lender 2,250,000 shares of its common stock as commitment shares at a fair value of $164,250.Subsequent to June 30, 2023, the Company entered into a loan agreement with a lender whereby the lender issued the Company a promissory note of $261,250. The note bears interest at a rate of 12% per annum, has a maturity date of April 30, 2024, and the Company is required to make monthly payments of $45,417 beginning in October of 2023. Upon an event of default, the note is convertible into the Company’s common stock at the lower of $0.04 per share or a price equal to 75% of the lowest trading price during the ten-day trading period before the conversion. As additional consideration for entering into the note, the Company issued the lender 2,000,000 shares of its restricted common stock as commitment shares at a fair value of $84,000 and warrants to purchase 6,531,250 shares of the Company’s common stock for an exercise price of $0.04 per share.Subsequent to June 30, 2023, the Company entered into a loan agreement with a lender whereby the lender issued the Company a promissory note of $143,000. The note bears interest at a rate of 10% per annum and a maturity date of July 27, 2024. Beginning January 27, 2024, the note is convertible into the Company’s common stock at a price equal to 65% of the lowest trading price during the ten-day trading period before the conversion.
CY2023Q2	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	261250	usd
CY2023Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
CY2023Q2	us-gaap	Investment Maturity Date InvestmentMaturityDate	2024-04-30
	crtd	Shares Of Common Stock SharesOfCommonStock	1093750	shares
CY2023Q2	us-gaap	Commitments Fair Value Disclosure CommitmentsFairValueDisclosure	44845	usd
	crtd	Exercise Of The Warrants ExerciseOfTheWarrants	231000	usd
CY2023Q2	crtd	Operating Lease Payable Long Term OperatingLeasePayableLongTerm		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023Q2	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities		usd
CY2022Q2	crtd	Derivative Expense DerivativeExpense		usd
	crtd	Derivative Expense DerivativeExpense		usd
CY2023Q2	crtd	Change In Derivative Liability ChangeInDerivativeLiability		usd
CY2022Q2	crtd	Change In Derivative Liability ChangeInDerivativeLiability		usd
	crtd	Change In Derivative Liability ChangeInDerivativeLiability		usd
CY2023Q2	crtd	Impairment Of Investment ImpairmentOfInvestment		usd
	crtd	Impairment Of Investment ImpairmentOfInvestment		usd
CY2023Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2023Q1	us-gaap	Dividends Dividends		usd
CY2022Q1	us-gaap	Dividends Dividends		usd
	crtd	Impairment Of Investment ImpairmentOfInvestment		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	crtd	Derivative Expense DerivativeExpense		usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
	crtd	Gain Losses On Extinguishment Of Debt GainLossesOnExtinguishmentOfDebt		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
	us-gaap	Noncash Contribution Expense NoncashContributionExpense		usd
	crtd	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	crtd	Cash Received From The Sale Of Minority Interest In Og Collection Inc CashReceivedFromTheSaleOfMinorityInterestInOGCollectionInc		usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	crtd	Shares Issued Convertible Notes Payable SharesIssuedConvertibleNotesPayable		usd
	crtd	Feature Issued With Convertible Note FeatureIssuedWithConvertibleNote		usd
	crtd	Shares Issued With Notes Payable SharesIssuedWithNotesPayable		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	crtd	Deemed Dividend DeemedDividend		usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2023Q2	crtd	Goodwill Acquired In A Business Combination GoodwillAcquiredInABusinessCombination		usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2023Q2	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	crtd	Share Based Compensation Award Options Weighted Average Remaining Contractual Life Granted ShareBasedCompensationAwardOptionsWeightedAverageRemainingContractualLifeGranted
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	crtd	Impairment Of Intangibles ImpairmentOfIntangibles		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	crtd	Impairment Of Intangibles ImpairmentOfIntangibles		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001357671

Files In Submission

Name	View Source	Status
0001213900-23-066977-index-headers.html	Edgar Link	pending
0001213900-23-066977-index.html	Edgar Link	pending
0001213900-23-066977.txt	Edgar Link	pending
0001213900-23-066977-xbrl.zip	Edgar Link	pending
crtd-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_creatdinc.htm	Edgar Link	pending
f10q0623ex31-2_creatdinc.htm	Edgar Link	pending
f10q0623ex32-1_creatdinc.htm	Edgar Link	pending
f10q0623ex32-2_creatdinc.htm	Edgar Link	pending
f10q0623_creatdinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
crtd-20230630_cal.xml	Edgar Link	unprocessable
crtd-20230630_def.xml	Edgar Link	unprocessable
crtd-20230630_lab.xml	Edgar Link	unprocessable
crtd-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_creatdinc_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTD
Creatd, Inc. Stock $crtd

2023 Q3 Form 10-Q Financial Statement

#000121390023066977 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTD Creatd, Inc. Stock $crtd

2023 Q3 Form 10-Q Financial Statement

#000121390023066977 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTD
Creatd, Inc. Stock $crtd